Dechra Pharmaceuticals Share Price (DPH)

985.75 -8.75 (-0.88%) delayed: 12:12AM GMT
Bid price 981.00 Open price 991.50
Ask price 990.50 Prev close 982.50
High price 993.08 Spread 0.96%
Low price 980.00 Volume 30,323

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 985.75 Net Gearing (%) 17.70
Market Capitalisation (£m) 874.84 Gross Gearing (%) 33.42
Shares in issue (m) 87.97 Debt Ratio 21.58
P/E Ratio 44.92 Debt-to-Equity Ratio 0.55
Total dividends per share (p) 16.94 Assets / Equity Ratio 1.50
Dividend Yield (%) 1.70 Price to book value 4.50
Dividend cover (x) 1.25 ROCE (%) 10.41
Earning per share (p) 22.14 EPS Growth (%) -67.23
52 week high / low 1,068.00 / 774.00 DPS Growth (%) 10.00

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
09/09/2015 EXR Anne-Françoise Nesmes FD 38,859
09/09/2015 SEXR Anne-Françoise Nesmes FD 18,319
12/09/2014 EXR Ian Page CEO 92,811
12/09/2014 SEXR Ian Page CEO 43,753
03/03/2014 EXR Ian Page CEO 78,656

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

09:11 16/11/2015

Additional Listing

/* */ RNS Number : 8002F Dechra Pharmaceuticals PLC 16 November 2015          16 November 2015   Dechra ® Pharmaceuticals PLC (Dechra or the Company)      Additional Listing...

08:33 11/11/2015

Director Declaration

/* */ RNS Number : 3127F Dechra Pharmaceuticals PLC 11 November 2015          11 November 2015   Dechra ® Pharmaceuticals PLC ("Dechra" or "the Company")  Director's Declaration  ...

14:33 30/10/2015

Total Voting Rights

/* */ RNS Number : 0697E Dechra Pharmaceuticals PLC 30 October 2015          30 October 2015   Dechra ® Pharmaceuticals PLC (Dechra or the Company)      In conformity with DTR...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...

Register now for FREE Dechra Pharmaceuticals share price discussions